Skip to main content
JAMA Network logoLink to JAMA Network
. 2020 Jun 17;5(6):732. doi: 10.1001/jamacardio.2020.2054

Errors in Text and Figure Caption

PMCID: PMC7301223

In the Original Investigation titled “Off-label Use of Direct Oral Anticoagulants Compared With Warfarin for Left Ventricular Thrombi,”1 published online April 22, 2020, errors appeared in the text and the legend to Figure 1. In the last sentence of the first paragraph of the Discussion section, the number of patients treated with an oral anticoagulant was 421, not 412. In the legend to Figure 1, “thromb1” should be changed to “thrombi,” the number of patients treated with apizamban was 141, not 150, and the number of patients treated with rivaroxaban was 46, not 51. The article has been corrected online.

References

  • 1.Robinson AA, Trankle CR, Eubanks G, et al. . Off-label use of direct oral anticoagulants compared with warfarin for left ventricular thrombi. JAMA Cardiol. Published online April 22, 2020. doi: 10.1001/jamacardio.2020.0652 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from JAMA Cardiology are provided here courtesy of American Medical Association

RESOURCES